Sponsor
Oncusp Therapeutics Inc.
433 Broadway, 10013-2510, United States
About the sponsor
Clinical research at Oncusp Therapeutics Inc. is centered on solid tumours with a strong focus on advanced and treatment-resistant disease settings, including platinum-resistant ovarian cancer and broader advanced solid tumours.
- Platinum-resistant ovarian cancer
- Platinum-refractory ovarian cancer
- Advanced solid tumours
The sponsor’s oncology portfolio reflects interest in cancers that remain difficult to treat after standard therapy, with attention to tumour types requiring new targeted options.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.